L. Westbrook

Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the TIME randomized trial.

Doris A Taylor, D. Gordon, T. Henry, 2012, JAMA.

Cell therapy and satellite centers: the Cardiovascular Cell Therapy Research Network experience.

T. Henry, C. Lambert, R. Simari, 2011, Contemporary clinical trials.

Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trial.

Dejian Lai, Saif Anwaruddin, Catalin Loghin, 2012, JAMA.

Oversight and management of a cell therapy clinical trial network: experience and lessons learned.

E. Handberg, S. Skarlatos, S. Anwaruddin, 2011, Contemporary clinical trials.

A randomized study of transendocardial injection of autologous bone marrow mononuclear cells and cell function analysis in ischemic heart failure (FOCUS-HF).

Scott D Flamm, Yi Zheng, T. Henry, 2011, American heart journal.

Intramyocardial injection of autologous bone marrow mononuclear cells for patients with chronic ischemic heart disease and left ventricular dysfunction (First Mononuclear Cells injected in the US [FOCUS]): Rationale and design.

B. Byrne, D. Gordon, T. Henry, 2010, American heart journal.